Welcome to LookChem.com Sign In|Join Free
  • or
(1R)-Phenyl-1,2,3,4-tetrahydroisoquinoline is an organic compound that is a counterpart to (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline. It is produced as a by-product in the synthesis of the latter enantiomer, which is a key intermediate in the preparation of Solifenacin (S676700), an antimuscarinic agent. (1R)-Phenyl-1,2,3,4-tetrahydroisoquinoline has potential applications in the pharmaceutical industry due to its structural similarity to the S enantiomer and its role in the synthesis of muscarinic receptor antagonists.

180272-45-1

Post Buying Request

180272-45-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

180272-45-1 Usage

Uses

Used in Pharmaceutical Industry:
(1R)-Phenyl-1,2,3,4-tetrahydroisoquinoline is used as a reagent for the preparation of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives. These derivatives act as muscarinic receptor antagonists, which have potential applications in the treatment of various conditions, such as overactive bladder, Alzheimer's disease, and other disorders related to the muscarinic system.
Additionally, (1R)-Phenyl-1,2,3,4-tetrahydroisoquinoline is considered for recycling to obtain the S enantiomer on a larger scale. This process could improve the efficiency of producing Solifenacin (S676700) and other related antimuscarinic agents, thereby contributing to the development of new treatments for various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 180272-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,2,7 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 180272-45:
(8*1)+(7*8)+(6*0)+(5*2)+(4*7)+(3*2)+(2*4)+(1*5)=121
121 % 10 = 1
So 180272-45-1 is a valid CAS Registry Number.

180272-45-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

1.2 Other means of identification

Product number -
Other names (R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:180272-45-1 SDS

180272-45-1Synthetic route

(R)-(+)-2-(4-methylphenylsulfonyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
220936-57-2

(R)-(+)-2-(4-methylphenylsulfonyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With samarium diiodide; water; triethylamine In tetrahydrofuran at 20℃; Inert atmosphere;99%
With ammonia; sodium In tetrahydrofuran at -78℃; for 0.75h;68%
(R)-2-benzyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline
1443308-76-6

(R)-2-benzyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With hydrogenchloride; 5%-palladium/activated carbon; hydrogen In ethanol; ethyl acetate at 20℃; under 760.051 Torr; for 24h; Schlenk technique;98%
C15H15N*C4H6O6

C15H15N*C4H6O6

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With water; sodium hydroxide In ethyl acetate at 20℃;97.9%
1-phenylisoquinoline
3297-72-1

1-phenylisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With bis(1,5-cyclooctadiene)diiridium(I) dichloride; trichloroisocyanuric acid; hydrogen; (R)-segphos In tetrahydrofuran at 80℃; under 62059.4 Torr; for 48h; Catalytic behavior; Reagent/catalyst; Solvent; Autoclave; enantioselective reaction;96%
With bis(1,5-cyclooctadiene)diiridium(I) dichloride; trichloroisocyanuric acid; hydrogen; (R)-segphos In tetrahydrofuran at 80℃; under 62059.4 Torr; for 48h; Catalytic behavior; Reagent/catalyst; Solvent; Glovebox; Autoclave;96%
Multi-step reaction with 3 steps
1: acetone / 24 h / 90 °C
2: bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; (Rax,S,S)-C3-TunePhos / dichloromethane; tetrahydrofuran / 20 h / 30 °C / 31029.7 Torr / Autoclave; Glovebox
3: hydrogen; hydrogenchloride; 5%-palladium/activated carbon / ethanol; ethyl acetate / 24 h / 20 °C / 760.05 Torr / Schlenk technique
View Scheme
Multi-step reaction with 3 steps
1: acetone / 24 h / 90 °C
2: bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; (+)-(R)-[2,3,2',3'-tetrahydro-5,5'-bi(1,4-benzodioxin)-6,6'-diyl]bis(diphenylphosphane) / dichloromethane; tetrahydrofuran / 20 h / 30 °C / 31029.7 Torr / Autoclave; Glovebox
3: hydrogen; hydrogenchloride; 5%-palladium/activated carbon / ethanol; ethyl acetate / 24 h / 20 °C / 760.05 Torr / Schlenk technique
View Scheme
1-phenyl-3,4-dihydroisoquinoline
52250-50-7

1-phenyl-3,4-dihydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Stage #1: 1-phenyl-3,4-dihydroisoquinoline With N-Bromosuccinimide; bis(1,5-cyclooctadiene)diiridium(I) dichloride; sodium carbonate; (+)-(R)-[2,3,2',3'-tetrahydro-5,5'-bi(1,4-benzodioxin)-6,6'-diyl]bis(diphenylphosphane) In 1,2-dichloro-ethane at 20℃; for 0.166667h;
Stage #2: With hydrogen In 1,2-dichloro-ethane at 30℃; under 25858.1 Torr; for 24h; enantioselective reaction;
94%
With N-Bromosuccinimide; bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; sodium carbonate; (R)-2,2'-bis(diphenylphosphanyl)-1,1'-binaphthyl In 1,2-dichloro-ethane at 30℃; under 25858.1 Torr; for 24h; Glovebox; enantioselective reaction;94%
With N-Bromosuccinimide; chloro(1,5-cyclooctadiene)rhodium(I) dimer; hydrogen; sodium carbonate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In 1,2-dichloro-ethane at 30℃; under 25858.1 Torr; for 24h; Glovebox; enantioselective reaction;94%
1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8

1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Stage #1: 1-phenyl-1,2,3,4-tetrahydroisoquinoline With N-Bromosuccinimide; bis(1,5-cyclooctadiene)diiridium(I) dichloride; sodium carbonate; (+)-(R)-[2,3,2',3'-tetrahydro-5,5'-bi(1,4-benzodioxin)-6,6'-diyl]bis(diphenylphosphane) In 1,2-dichloro-ethane at 20℃; for 0.166667h;
Stage #2: With hydrogen In 1,2-dichloro-ethane at 30℃; under 25858.1 Torr; for 24h; enantioselective reaction;
93%
With L-(-)-tartaric acid In methanol Resolution of racemate;
With potassium hydroxide In water; dimethyl sulfoxide for 11.8333h; Purification / work up; Heating / reflux;
1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8

1-phenyl-1,2,3,4-tetrahydroisoquinoline

A

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With borane-ammonia complex; 6-hydroxy-D-nicotine oxidase E350L/E352D mutant for 120h; Kinetics; Enzymatic reaction; enantioselective reaction;A n/a
B 86%
With D-tartaric acid Resolution of racemate;A 79%
B 2.78 g
Stage #1: 1-phenyl-1,2,3,4-tetrahydroisoquinoline With D-tartaric acid In water Resolution of racemate;
Stage #2: With sodium hydroxide In water at 20℃; Purification / work up;
A n/a
B n/a
(1R)-N-(8-menthyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
321670-05-7

(1R)-N-(8-menthyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Stage #1: (1R)-N-(8-menthyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline With 3 A molecular sieve; sodium acetate; pyridinium chlorochromate In dichloromethane at 20℃; for 48h;
Stage #2: With potassium hydroxide In tetrahydrofuran Further stages.;
82%
(1E)-4-hydroxy-1-mesityl-4-methylpent-1-en-3-one
1346681-71-7

(1E)-4-hydroxy-1-mesityl-4-methylpent-1-en-3-one

1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8

1-phenyl-1,2,3,4-tetrahydroisoquinoline

A

(1S)-2-(3-mesitylpropanoyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
1346681-99-9

(1S)-2-(3-mesitylpropanoyl)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

C

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With 2-(2,4,6-trimethyl-phenyl)-2,5,6,7-tetrahydro-pyrrolo[2,1-c] [1,2,4]triazol-4-ylium perchlorate; (4aR,9aS)-4-hydroxy-4,4a,9,9a-tetrahydroindeno[2,1-b][1,4]oxazin-3(2H)-one; 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 23℃; for 18h; Inert atmosphere; Resolution of racemate; optical yield given as %ee; enantioselective reaction;A 49%
B n/a
C n/a
(1R,5S)-1,3,8,8-Tetramethyl-5-((R)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-aza-bicyclo[3.2.1]octane-2,4-dione

(1R,5S)-1,3,8,8-Tetramethyl-5-((R)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-aza-bicyclo[3.2.1]octane-2,4-dione

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether at 0℃; for 48h;42%
With lithium aluminium tetrahydride In diethyl ether at 0℃; for 48h; Yield given;
(1S,5R)-5,8,8-trimethyl-1-[(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyl]-3-oxabicyclo[3.2.1]octan-2-one
660861-59-6

(1S,5R)-5,8,8-trimethyl-1-[(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyl]-3-oxabicyclo[3.2.1]octan-2-one

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With Li[AlH2(OCH3)2] In tetrahydrofuran at -50℃; for 72h;35%
1-phenyl-3,4-dihydroisoquinoline
52250-50-7

1-phenyl-3,4-dihydroisoquinoline

A

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With sodium tetrahydroborate In ethanol at 20℃; for 60h;
With hydrogen; bis(1,5-cyclooctadiene)diiridium(I) dichloride; (S)-(1,1'-binaphthalene)-2,2'-diylbis(diphenylphosphine) In tetrahydrofuran; 1,1-dichloroethane at 20 - 50℃; under 22502.3 Torr; Product distribution / selectivity; Inert atmosphere;A n/a
B n/a
With 1,1'-bis-(diphenylphosphino)ferrocene; bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; iodine In dichloromethane at 20℃; under 38002.6 Torr; for 24h; Inert atmosphere; Autoclave; optical yield given as %ee; enantioselective reaction;
N-phenethylbenzamide
3278-14-6

N-phenethylbenzamide

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: P2O5; POCl3 / xylene / 2.5 h / Heating
2: NaBH4 / ethanol / 60 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: PPA / water / 4.25 h / 14.9 - 165 °C
1.2: 0.17 h / 28 - 42 °C / pH 2.1 - 7.12
2.1: methanol; sodium tetrahydroborate / water / 5.42 h / 20 - 34 °C
3.1: potassium hydroxide / water; dimethyl sulfoxide / 11.83 h / Heating / reflux
View Scheme
2-bromophenylacetaldehyde
96557-30-1

2-bromophenylacetaldehyde

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 97 percent / CH2Cl2 / 20 °C
2.1: NaBH4; BF3*OEt2 / tetrahydrofuran / 2 h / 20 °C
2.2: 90 percent / NaOH / H2O / 1 h / Heating
3.1: 85 percent / 120 °C
4.1: t-BuLi / diethyl ether; pentane / 0.17 h / -90 °C
4.2: 78 percent / Et2AlCl / hexane / -90 - 20 °C
5.1: PCC; NaOAc; 3A molecular sieves / CH2Cl2 / 48 h / 20 °C
5.2: 82 percent / KOH / tetrahydrofuran
View Scheme
ortho-bromobenzaldehyde
6630-33-7

ortho-bromobenzaldehyde

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: potassium tert-butoxide / tetrahydrofuran / 0.5 h / 0 °C
1.2: tetrahydrofuran / 12 h / 20 °C
1.3: 95 percent / formic acid / CH2Cl2 / 72 h / 20 °C
2.1: 97 percent / CH2Cl2 / 20 °C
3.1: NaBH4; BF3*OEt2 / tetrahydrofuran / 2 h / 20 °C
3.2: 90 percent / NaOH / H2O / 1 h / Heating
4.1: 85 percent / 120 °C
5.1: t-BuLi / diethyl ether; pentane / 0.17 h / -90 °C
5.2: 78 percent / Et2AlCl / hexane / -90 - 20 °C
6.1: PCC; NaOAc; 3A molecular sieves / CH2Cl2 / 48 h / 20 °C
6.2: 82 percent / KOH / tetrahydrofuran
View Scheme
2α-(2'-bromophenylmethyl)-4,4,7α-trimethyl-trans-octahydro-1,3-benzoxazine
321669-61-8

2α-(2'-bromophenylmethyl)-4,4,7α-trimethyl-trans-octahydro-1,3-benzoxazine

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaBH4; BF3*OEt2 / tetrahydrofuran / 2 h / 20 °C
1.2: 90 percent / NaOH / H2O / 1 h / Heating
2.1: 85 percent / 120 °C
3.1: t-BuLi / diethyl ether; pentane / 0.17 h / -90 °C
3.2: 78 percent / Et2AlCl / hexane / -90 - 20 °C
4.1: PCC; NaOAc; 3A molecular sieves / CH2Cl2 / 48 h / 20 °C
4.2: 82 percent / KOH / tetrahydrofuran
View Scheme
N-[(2'-bromophenyl)ethyl]-8-aminomenthol
321669-65-2

N-[(2'-bromophenyl)ethyl]-8-aminomenthol

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 85 percent / 120 °C
2.1: t-BuLi / diethyl ether; pentane / 0.17 h / -90 °C
2.2: 78 percent / Et2AlCl / hexane / -90 - 20 °C
3.1: PCC; NaOAc; 3A molecular sieves / CH2Cl2 / 48 h / 20 °C
3.2: 82 percent / KOH / tetrahydrofuran
View Scheme
3-[(2'-bromophenyl)ethyl]-2α-phenyl-4,4,7α-trimethyl-trans-octahydro-1,3-benzoxazine
321669-82-3

3-[(2'-bromophenyl)ethyl]-2α-phenyl-4,4,7α-trimethyl-trans-octahydro-1,3-benzoxazine

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: t-BuLi / diethyl ether; pentane / 0.17 h / -90 °C
1.2: 78 percent / Et2AlCl / hexane / -90 - 20 °C
2.1: PCC; NaOAc; 3A molecular sieves / CH2Cl2 / 48 h / 20 °C
2.2: 82 percent / KOH / tetrahydrofuran
View Scheme
phenyl N-tosyl imine
51608-60-7

phenyl N-tosyl imine

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) n-butyllithium / 1.) hexane, THF, -100 deg C, 15 min, 2.) THF, -85 to -100 deg C, 6 h
2: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
3: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
4: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
(4R,5R)-2-(2-Bromo-benzyl)-4,5-bis-(1-methoxy-1-methyl-ethyl)-[1,3]dioxolane
172794-67-1

(4R,5R)-2-(2-Bromo-benzyl)-4,5-bis-(1-methoxy-1-methyl-ethyl)-[1,3]dioxolane

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) n-butyllithium / 1.) hexane, THF, -100 deg C, 15 min, 2.) THF, -85 to -100 deg C, 6 h
2: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
3: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
4: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
Multi-step reaction with 6 steps
1: 1.) n-butyllithium / 1.) hexane, THF, -100 deg, 2 h, 2.) THF, 0 deg C, 2 h
2: 53 percent / ammonium cerium(IV) nitrate / methanol; H2O / 3 h / Ambient temperature
3: 81 percent / Et3N / tetrahydrofuran / 8 h / Ambient temperature
4: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
5: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
6: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
4-methoxy-N-[(E)-phenylmethylidene]aniline
1613-90-7

4-methoxy-N-[(E)-phenylmethylidene]aniline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1.) n-butyllithium / 1.) hexane, THF, -100 deg, 2 h, 2.) THF, 0 deg C, 2 h
2: 53 percent / ammonium cerium(IV) nitrate / methanol; H2O / 3 h / Ambient temperature
3: 81 percent / Et3N / tetrahydrofuran / 8 h / Ambient temperature
4: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
5: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
6: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
N-<(αR and αS)-2-<<(4R,5R)-4,5-bis(2-methoxypropan-2-yl)-1,3-dioxolan-2-yl>methyl>benzhydryl>-4-methoxyaniline

N-<(αR and αS)-2-<<(4R,5R)-4,5-bis(2-methoxypropan-2-yl)-1,3-dioxolan-2-yl>methyl>benzhydryl>-4-methoxyaniline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 53 percent / ammonium cerium(IV) nitrate / methanol; H2O / 3 h / Ambient temperature
2: 81 percent / Et3N / tetrahydrofuran / 8 h / Ambient temperature
3: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
4: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
5: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
(-)-N-<(αR)-2-<<(4R,5R)-4,5-bis(2-methoxypropan-2-yl)-1,3-dioxolan-2-yl>methyl>benzhydryl>-4-methylbenzenesulfonamide
213595-50-7

(-)-N-<(αR)-2-<<(4R,5R)-4,5-bis(2-methoxypropan-2-yl)-1,3-dioxolan-2-yl>methyl>benzhydryl>-4-methylbenzenesulfonamide

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
2: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
3: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
(R)-(+)-2-(4-methylphenylsulfonyl)-1-phenyl-1,2-dihydroisoquinoline
220936-55-0

(R)-(+)-2-(4-methylphenylsulfonyl)-1-phenyl-1,2-dihydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
2: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
C-{2-[4,5-bis-(1-methoxy-1-methyl-ethyl)-[1,3]dioxolan-2-ylmethyl]-phenyl}-C-phenyl-methylamine

C-{2-[4,5-bis-(1-methoxy-1-methyl-ethyl)-[1,3]dioxolan-2-ylmethyl]-phenyl}-C-phenyl-methylamine

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 81 percent / Et3N / tetrahydrofuran / 8 h / Ambient temperature
2: 48 percent / p-TsOH, conc. HCl / methanol; H2O / 96 h / Heating
3: 90 percent / LiAlH4 / tetrahydrofuran / 16 h / Heating
4: 68 percent / Na, liquid ammonia / tetrahydrofuran / 0.75 h / -78 °C
View Scheme
(1R,5S)-1,3,8,8-Tetramethyl-5-(1-phenyl-1H-isoquinoline-2-carbonyl)-3-aza-bicyclo[3.2.1]octane-2,4-dione

(1R,5S)-1,3,8,8-Tetramethyl-5-(1-phenyl-1H-isoquinoline-2-carbonyl)-3-aza-bicyclo[3.2.1]octane-2,4-dione

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 13 percent / H2 / Pd/C / ethanol / 48 h
2: 42 percent / LiAlH4 / diethyl ether / 48 h / 0 °C
View Scheme
Multi-step reaction with 2 steps
1: H2 / Pd/C / ethanol / 48 h / Ambient temperature
2: LiAlH4 / diethyl ether / 48 h / 0 °C
View Scheme
4-nitrophenyl-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
881834-78-2

4-nitrophenyl-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

A

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Stage #1: 4-nitrophenyl-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate With sodium hydroxide In ethanol at 75 - 80℃;
Stage #2: With water Cooling;
N-chloroacetyl-(1R)-phenyl-1,2,3,4-tetrahydroisoquinoline
1085541-60-1

N-chloroacetyl-(1R)-phenyl-1,2,3,4-tetrahydroisoquinoline

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride; water; phosphoric acid / 95 - 100 °C
1.2: 20 °C / pH 9 - 10
2.1: D-tartaric acid / water / Resolution of racemate
2.2: 20 °C
View Scheme
N-phenethylbenzamide
3278-14-6

N-phenethylbenzamide

A

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2-chloropyridine; trifluoromethylsulfonic anhydride / dichloromethane / -78 - 20 °C / Inert atmosphere
2: 1,1'-bis-(diphenylphosphino)ferrocene; bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; iodine / dichloromethane / 24 h / 20 °C / 38002.6 Torr / Inert atmosphere; Autoclave
View Scheme
Multi-step reaction with 2 steps
1.1: phosphorus pentoxide; trichlorophosphate / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / 140 °C
1.2: 1 h
2.1: bis(1,5-cyclooctadiene)diiridium(I) dichloride; phosphoric acid; (R)-2,2'-bis(diphenylphosphanyl)-1,1'-binaphthyl; potassium iodide / tetrahydrofuran / 16 h / 50 °C / 22502.3 Torr
View Scheme
Multi-step reaction with 3 steps
1.1: phosphorus pentoxide; trichlorophosphate / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / 140 °C
1.2: 1 h
2.1: palladium on activated charcoal; hydrogen / 30 °C / 3750.38 Torr
3.1: trifluoroacetic acid / methanol; ethanol; hexane / 25 °C / Resolution of racemate
View Scheme
benzoyl chloride
98-88-4

benzoyl chloride

A

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8, 96719-89-0, 118864-75-8

(S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

B

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 0 - 20 °C
2: 2-chloropyridine; trifluoromethylsulfonic anhydride / dichloromethane / -78 - 20 °C / Inert atmosphere
3: 1,1'-bis-(diphenylphosphino)ferrocene; bis(1,5-cyclooctadiene)diiridium(I) dichloride; hydrogen; iodine / dichloromethane / 24 h / 20 °C / 38002.6 Torr / Inert atmosphere; Autoclave
View Scheme
Multi-step reaction with 3 steps
1.1: dichloromethane / 2 h / 0 - 5 °C
1.2: 6 h / 0 °C / Reflux
2.1: phosphorus pentoxide; trichlorophosphate / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / 140 °C
2.2: 1 h
3.1: bis(1,5-cyclooctadiene)diiridium(I) dichloride; phosphoric acid; (R)-2,2'-bis(diphenylphosphanyl)-1,1'-binaphthyl; potassium iodide / tetrahydrofuran / 16 h / 50 °C / 22502.3 Torr
View Scheme
Multi-step reaction with 4 steps
1.1: dichloromethane / 2 h / 0 - 5 °C
1.2: 6 h / 0 °C / Reflux
2.1: phosphorus pentoxide; trichlorophosphate / 5,5-dimethyl-1,3-cyclohexadiene / 5 h / 140 °C
2.2: 1 h
3.1: palladium on activated charcoal; hydrogen / 30 °C / 3750.38 Torr
4.1: trifluoroacetic acid / methanol; ethanol; hexane / 25 °C / Resolution of racemate
View Scheme
(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

1-phenyl-1,2,3,4-tetrahydroisoquinoline
22990-19-8

1-phenyl-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
With water; potassium hydroxide In dimethyl sulfoxide at 120℃; for 10h;92.1%
With potassium hydroxide; water In dimethyl sulfoxide at 160℃; for 15h;
Multi-step reaction with 2 steps
1.1: triethylamine / dichloromethane / -10 - 20 °C
2.1: hydrogenchloride; water; phosphoric acid / 95 - 100 °C
2.2: 20 °C / pH 9 - 10
View Scheme
(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

1-phenyl-3,4-dihydroisoquinoline
52250-50-7

1-phenyl-3,4-dihydroisoquinoline

Conditions
ConditionsYield
With dimethyl sulfoxide at 100℃; for 24h; Solvent; Temperature; Schlenk technique; Green chemistry; chemoselective reaction;87%
Multi-step reaction with 2 steps
1: trichloroisocyanuric acid / dichloromethane / 1.5 h / 3 - 5 °C
2: potassium hydroxide / methanol / 1 h / 20 °C
View Scheme
With hydrogenchloride; oxygen In aq. phosphate buffer at 37℃; pH=7.8;
With air In N,N-dimethyl-formamide at 100℃; for 24h; Schlenk technique; Green chemistry;
chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

ethyl (R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
180468-41-1

ethyl (R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

Conditions
ConditionsYield
With potassium carbonate In dichloromethane at 20℃;
(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
774517-20-3

(3S)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / CH2Cl2 / 20 °C
2: NaH / toluene / Heating
View Scheme
(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
180272-45-1

(R)-(-)-1-phenyl-1,2,3,4-tetrahydroisoquinoline

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate
740780-79-4

(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / CH2Cl2 / 20 °C
2: NaH / toluene / Heating
View Scheme

180272-45-1Relevant academic research and scientific papers

Low-Temperature Nickel-Catalyzed C?N Cross-Coupling via Kinetic Resolution Enabled by a Bulky and Flexible Chiral N-Heterocyclic Carbene Ligand

Hong, Xin,Shi, Shi-Liang,Wang, Zi-Chao,Xie, Pei-Pei,Xu, Youjun

supporting information, p. 16077 - 16084 (2021/06/17)

The transition-metal-catalyzed C?N cross-coupling has revolutionized the construction of amines. Despite the innovations of multiple generations of ligands to modulate the reactivity of the metal center, ligands for the low-temperature enantioselective amination of aryl halides remain a coveted target of catalyst engineering. Designs that promote one elementary reaction often create bottlenecks at other steps. We here report an unprecedented low-temperature (as low as ?50 °C), enantioselective Ni-catalyzed C?N cross-coupling of aryl chlorides with sterically hindered secondary amines via a kinetic resolution process (s factor up to >300). A bulky yet flexible chiral N-heterocyclic carbene (NHC) ligand is leveraged to drive both oxidative addition and reductive elimination with low barriers and control the enantioselectivity. Computational studies indicate that the rotations of multiple σ-bonds on the C2-symmetric chiral ligand adapt to the changing needs of catalytic processes. We expect this design would be widely applicable to diverse transition states to achieve other challenging metal-catalyzed asymmetric cross-coupling reactions.

Asymmetric Transfer Hydrogenation of Unhindered and Non-Electron-Rich 1-Aryl Dihydroisoquinolines with High Enantioselectivity

Barrios-Rivera, Jonathan,Xu, Yingjian,Wills, Martin

, p. 6283 - 6287 (2020/09/02)

The use of arene/Ru/TsDPEN catalysts bearing a heterocyclic group on the TsDPEN in the asymmetric transfer hydrogenation (ATH) of dihydroisoquinolines (DHIQs) containing meta- or para-substituted aromatic groups at the 1-position results in the formation of products of high enantiomeric excess. Previously, only 1-(ortho-substituted)aryl DHIQs, or with an electron-rich fused ring gave products with high enantioselectivity; therefore, this approach solves a long-standing challenge for imine ATH.

Josiphos-Type Binaphane Ligands for Iridium-Catalyzed Enantioselective Hydrogenation of 1-Aryl-Substituted Dihydroisoquinolines

Nie, Huifang,Zhu, Yupu,Hu, Xiaomu,Wei, Zhao,Yao, Lin,Zhou, Gang,Wang, Pingan,Jiang, Ru,Zhang, Shengyong

, p. 8641 - 8645 (2019/10/17)

Convenient synthesis and useful application of a series of Josiphos-type binaphane ligands were described. The iridium complexes of these chiral diphosphines displayed excellent enantioselectivity and good reactivity in the asymmetric hydrogenation of challenging 1-aryl-substituted dihydroisoquinoline substrates (full conversions, up to >99% ee, 4000 TON). The use of 40% HBr (aqueous solution) as an additive dramatically improved the asymmetric induction of these catalysts. This transformation provided a highly efficient and enantioselective access to chiral 1-aryl-substituted tetrahydroisoquinolines, which were of great importance and common in natural products and biologically active molecules.

A through halogen bond activation isoquinoline asymmetric hydrogenation method

-

Paragraph 0031-0040; 0062, (2019/03/26)

A through halogen bond activation isoquinoline asymmetric hydrogenation method, the catalyzing system is [...] complex, the activator is a halide. The reaction can be carried out under the following conditions, temperature: 25 - 100 °C; solvent: tetrahydr

Asymmetric Transfer Hydrogenation in Thermomorphic Microemulsions Based on Ionic Liquids

Hejazifar, Mahtab,Pálv?lgyi, ádám Márk,Bitai, Jacqueline,Lanaridi, Olga,Bica-Schr?der, Katharina

, p. 1841 - 1851 (2019/10/11)

A thermomorphic ionic-liquid-based microemulsion system was successfully applied for the Ru-catalyzed asymmetric transfer hydrogenation of ketones. On the basis of the temperature-dependent multiphase behavior of the targeted microemulsion, simple product separation as well as catalyst recycling could be realized. The use of water-soluble ligands improved the immobilization of the catalyst in the microemulsion phase and significantly decreased the catalyst leaching into the organic layer upon extraction of the product. Eventually, the optimized microemulsion system could be applied to a wide range of aromatic ketones that were reduced with good isolated yields (up to 98%) and enantioselectivities (up to 97%), while aliphatic ketones were less successful.

Breaking Symmetry: Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzymes

Wu, Shuke,Zhou, Yi,Rebelein, Johannes G.,Kuhn, Miriam,Mallin, Hendrik,Zhao, Jingming,Igareta, Nico V.,Ward, Thomas R.

supporting information, p. 15869 - 15878 (2019/10/11)

The biotin-streptavidin technology has been extensively exploited to engineer artificial metalloenzymes (ArMs) that catalyze a dozen different reactions. Despite its versatility, the homotetrameric nature of streptavidin (Sav) and the noncooperative binding of biotinylated cofactors impose two limitations on the genetic optimization of ArMs: (i) point mutations are reflected in all four subunits of Sav, and (ii) the noncooperative binding of biotinylated cofactors to Sav may lead to an erosion in the catalytic performance, depending on the cofactor:biotin-binding site ratio. To address these challenges, we report on our efforts to engineer a (monovalent) single-chain dimeric streptavidin (scdSav) as scaffold for Sav-based ArMs. The versatility of scdSav as host protein is highlighted for the asymmetric transfer hydrogenation of prochiral imines using [Cp*Ir(biot-p-L)Cl] as cofactor. By capitalizing on a more precise genetic fine-tuning of the biotin-binding vestibule, unrivaled levels of activity and selectivity were achieved for the reduction of challenging prochiral imines. Comparison of the saturation kinetic data and X-ray structures of [Cp*Ir(biot-p-L)Cl]·scdSav with a structurally related [Cp*Ir(biot-p-L)Cl]·monovalent scdSav highlights the advantages of the presence of a single biotinylated cofactor precisely localized within the biotin-binding vestibule of the monovalent scdSav. The practicality of scdSav-based ArMs was illustrated for the reduction of the salsolidine precursor (500 mM) to afford (R)-salsolidine in 90% ee and >17 ?000 TONs. Monovalent scdSav thus provides a versatile scaffold to evolve more efficient ArMs for in vivo catalysis and large-scale applications.

Chiral Carboxylic Acid Enabled Achiral Rhodium(III)-Catalyzed Enantioselective C?H Functionalization

Lin, Luqing,Fukagawa, Seiya,Sekine, Daichi,Tomita, Eiki,Yoshino, Tatsuhiko,Matsunaga, Shigeki

supporting information, p. 12048 - 12052 (2018/09/11)

Reported is an achiral CpxRhIII/chiral carboxylic acid catalyzed asymmetric C?H alkylation of diarylmethanamines with a diazomalonate, followed by cyclization and decarboxylation to afford 1,4-dihydroisoquinolin-3(2H)-one. Secondary

Solifenacin succinate raw medicine synthesis process

-

Paragraph 0038; 0111; 0113, (2018/08/28)

The invention discloses a solifenacin succinate raw medicine synthesis process. 2-phenylethylamine and 3-quinuclidinone hydrochloride are respectively used as starting raw materials for synthesizing afragment A and a fragment B; then, condensation reaction occurs to generate solifenacin; through salt formation, the solifenacin succinate is obtained. The process is characterized in that straight-chain paraffin and water are used as reaction solvents; alkali metal hydroxides or carbonate and bicarbonates of the alkali metal hydroxides are used as acid-binding agents; phenylethylamine and benzoyl chloride take acylation reaction to generate midbodies 1 of solid precipitation fragments A insoluble in reaction solvents; in the post treatment process, filtering is directly performed; isomers ofthe fragment A are subjected to catalytic racemization through alkali metal hydroxides by using dimethylsulfoxide as a solvent, so that the byproduct isomers can be recovered and utilized; in the second-step reaction post treatment of the fragment B, a conventional pressure reduced distillation method is used for obtaining high-purity and high-yield 3-acetoxyquinine acetate. The invention provides a novel synthesis process with the advantages of high yield and economic and environment-friendly effects, and is suitable for industrial mass production.

Dual Stereocontrol for Enantioselective Hydrogenation of Dihydroisoquinolines Induced by Tuning the Amount of N-Bromosuccinimide

Ji, Yue,Wang, Jie,Chen, Muwang,Shi, Lei,Zhou, Yonggui

supporting information, p. 139 - 142 (2018/01/05)

An efficient dual stereocontrol in iridium-catalyzed hydrogenation of 1-substituted 3,4-dihydroisoquinolines was realized by tuning the amount of N-bromosuccinimide using chiral ligand of single configuration, providing both enantiomers of 1-substituted 1,2,3,4-tetrahydroisoquinolines with up to 89% ee (S) and 98% ee (R), respectively. Dual activation role of N-bromosuccinimide is proposed to be responsible for the reversal of enantioselectivity under two hydrogenation conditions.

A one-pot process for the enantioselective synthesis of tetrahydroquinolines and tetrahydroisoquinolines: Via asymmetric reductive amination (ARA)

Yang, Tao,Yin, Qin,Gu, Guoxian,Zhang, Xumu

supporting information, p. 7247 - 7250 (2018/07/05)

Asymmetric reductive amination for the synthesis of both chiral tetrahydroquinolines (THQs) and tetrahydroisoquinolines (THIQs) has been realized with an Ir/ZhaoPhos catalytic system via a one-pot N-Boc deprotection/intramolecular asymmetric reductive amination (ARA) sequence. Control experiments reveal that HCl plays a vital role to the success of this transformation. The HCl acid assists the removal of the N-Boc protecting group and also provides chloride ions to interact with the thiourea moiety in ZhaoPhos, thus leading to excellent reaction enantiocontrol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 180272-45-1